Ofloxacin

   
Google
 
Web NewDrugInformation.com

Ofloxacin


Drug - Ofloxacin
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Ofloxacin
Multiple ingredients are in alphabetical order.

Strength - 400MG
The potency of the active ingredient(s), Ofloxacin. May repeat for multiple part products.

Applicant - TEVA
The firm name holding legal responsibility for Ofloxacin. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 076182
The FDA assigned number to Ofloxacin. Format is nnnnnn.

Product Number - 003
The FDA assigned number to identify Ofloxacin. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AB
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Sep 2, 2003
The date Ofloxacin was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Ofloxacin. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Ofloxacin is in. Format is RX, OTC, DISCN.

Applicant Full Name - Teva Pharmaceuticals Usa Inc
The full name of the firm holding legal responsibility for the new application of Ofloxacin.

Ofloxacin